We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SEATTLE, Jan. 28 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced that the National Institute on Drug Abuse (NIDA) is providing support for the Company's Addiction...
SEATTLE, Nov. 19 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER) today announced unaudited financial results for the third quarter ended September 30, 2009. For the three months...
SEATTLE, WA, Nov. 13 /PRNewswire-FirstCall/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...
SEATTLE, Wash., Oct. 7 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per...
SEATTLE, Sept. 18 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.27 | -6.26450116009 | 4.31 | 4.33 | 3.97 | 4929 | 4.09124128 | DE |
4 | 0 | 0 | 4.04 | 4.48 | 3.75 | 6107 | 4.06696246 | DE |
12 | 0.07 | 1.76322418136 | 3.97 | 4.6 | 3.75 | 8551 | 4.24406199 | DE |
26 | 0.33 | 8.8948787062 | 3.71 | 4.6 | 3.61 | 7560 | 4.07225711 | DE |
52 | 1.34 | 49.6296296296 | 2.7 | 4.6 | 2.65 | 11743 | 3.61530837 | DE |
156 | 0.255 | 6.73712021136 | 3.785 | 4.6 | 2.15 | 10693 | 3.26082613 | DE |
260 | 0.34 | 9.18918918919 | 3.7 | 4.6 | 2.15 | 15216 | 3.50110869 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions